Takeda Secures Global Rights to Ascentage Pharma’s Olverembatinib Outside of China and Select Territories
Takeda Pharmaceuticals, a leading biopharmaceutical company based in Japan (TYO: 4502), has entered into an...
Deals
AbbVie Strikes Deal with FutureGen for Global Rights to Next-Gen TL1A Antibody FG-M701
AbbVie (NYSE: ABBV), a biopharmaceutical giant based in the US, has announced a licensing agreement...
BeiGene to Terminate Partnership with NewBridge Pharmaceuticals for MENA Region
BeiGene (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a leading biopharmaceutical company based in China, has...
Ethypharm Expands in China’s IBD Market with Acquisition of Mesalazine Suppository
Ethypharm, a France-based pharmaceutical company, has announced that its Chinese subsidiary, Shanghai Ethypharmaceuticals Ltd, has...
Sihuan’s Xuanzhu Biopharmaceutical Strikes Licensing Deal with Livzon Pharmaceutical for Fadanafil
Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has declared that its subsidiary, Xuanzhu Biopharmaceutical Co.,...
Ronovo Surgical Secures Over RMB 300 Million in Series B to Globalize Surgical Robot
Shanghai-based surgical robotics specialist, Ronovo Surgical, has reportedly raised over RMB 300 million (USD 41.3...
Cellbri Bio Secures Nearly RMB 200 Million in Series B Financing to Boost CGT Commercialization
Shenzhen Cellbri Bio-Innovation Technology Co., Ltd, a prominent player in China’s cell and gene therapy...
Zhejiang Dian Diagnostics Partners with Quest Diagnostics to Advance Alzheimer’s Disease Blood Tests
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a leading diagnostics company based in China, has...
GSK Partners with Ochre Bio to Access Liver Data for Hepatology Therapy Development
GlaxoSmithKline (GSK; NYSE: GSK), a UK-based pharmaceutical giant, has entered into an agreement with fellow...
Chia Tai Tianqing and China Resource Medicine Commercial Holdings Join Forces for Pharmaceutical Industry Expansion
Chia Tai Tianqing, a renowned name in the Chinese healthcare industry, has forged a strategic...
Pfizer Forges Partnership with Flagship Pioneering for Novel Obesity Treatments
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has initiated a strategic partnership with Flagship Pioneering, a...
Johnson & Johnson to Acquire Biotechnology Firm Yellow Jersey for $1.25 Billion
Johnson & Johnson (J&J; NYSE: JNJ), a global healthcare conglomerate, has entered into a definitive...
Recorna and Starna Therapeutics Join Forces to Advance RNA Gene Editing in Lung Diseases
Recorna (Guangzhou) Biotechnology Co., Ltd, a pioneering RNA editing therapy startup based in China, has...
China Medical System Secures Exclusive Rights to Baiyiyuan Biotech’s Implant in Greater China
China Medical System Holdings (CMS; HKG: 0867) has entered into a licensing agreement with Shanghai-based...
Shanghai Turtle Technology Partners with Focusgen Biotech to Advance Tumor Liquid Biopsy Innovations
Shanghai Turtle Technology Co., Ltd, a leading Polymerase Chain Reaction (PCR) specialist in China, has...
MSD Makes Undisclosed Equity Investment in Cancer Diagnostics Firm DELFI Diagnostics
Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced an equity investment into DELFI Diagnostics,...
GSK Finalizes Acquisition of Oligonucleotide Specialist Elsie Biotechnologies for Up to $50 Million
GlaxoSmithKline (GSK; NYSE: GSK), a leading UK pharmaceutical company, has announced the completion of the...
Alphamab Oncology Partners with ArriVent BioPharma for Global ADC Development and Commercialization
Alphamab Oncology (HKG: 9966), a biopharmaceutical company based in China, has entered into a research...
3SBio Secures Exclusive Licensing Agreement for Seven Drug Candidates from Subsidiary
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd, a subsidiary of 3SBio Inc. (HKG: 1530), has disclosed...
Cloudbreak Pharma Files for Hong Kong IPO with Focus on Ophthalmic Innovations
Cloudbreak Pharma Inc., a Cayman Islands-registered pharmaceutical company, has filed for an initial public offering...